Ameriprise Financial Sells Medtronic Shares

Institutional investor decreases stake in medical device company

Mar. 15, 2026 at 7:45am

Got story updates? Submit your updates here. ›

Ameriprise Financial Inc. decreased its holdings in Medtronic PLC by 14.1% in the third quarter, according to the company's most recent 13F filing with the SEC. The institutional investor owned 12,534,866 shares of the medical technology company's stock after selling 2,062,814 shares.

Why it matters

This transaction highlights the shifting investment strategies of major institutional investors like Ameriprise as they adjust their portfolios in response to market conditions and outlook for specific companies.

The details

Ameriprise Financial sold 2,062,814 shares of Medtronic, reducing its stake in the medical device company by 14.1%. The institutional investor now owns 12,534,866 shares of Medtronic, which was worth $1,193,934,000 as of the most recent 13F filing.

  • Ameriprise Financial decreased its Medtronic holdings in the third quarter of 2026.

The players

Ameriprise Financial Inc.

A major American financial services company that provides financial planning, asset management and insurance products and services.

Medtronic PLC

A global medical technology company that develops and manufactures therapeutic medical devices and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

This transaction reflects the ongoing shifts in the investment landscape as major institutional investors like Ameriprise adjust their portfolios in response to market conditions and outlooks for specific companies like Medtronic.